Clinical Trial Update: A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on sunitinib plus lanreotide versus placebo plus lanreotide in patients with progressive advanced/metastatic midgut carcinoid tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumors

Drugs mentioned

• Lanreotide (lanreotide)
• Sunitinib (sunitinib)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Carcinoid Tumors | Phase 2 | Status: UNKNOWN